#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Fifty Years On: GWAS Confirms the Role of a Rare Variant in Lung Disease


article has not abstract


Vyšlo v časopise: Fifty Years On: GWAS Confirms the Role of a Rare Variant in Lung Disease. PLoS Genet 9(8): e32767. doi:10.1371/journal.pgen.1003768
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003768

Souhrn

article has not abstract


Zdroje

1. ThunGA, ImbodenM, FerrarottiI, KumarA, ObeidatM, et al. (2013) Causal and synthetic associations of variants in the serpina gene cluster with alpha1-antitrypsin serum levels. PLoS Genet 9 (8) e1003585 doi:10.1371/journal.pgen.1003585

2. ObeidatM, WainLV, ShrineN, KalshekerN, ArtigasMS, et al. (2011) A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample. PLoS One 6: e19382.

3. SorheimIC, BakkeP, GulsvikA, PillaiSG, JohannessenA, et al. (2010) alpha(1)-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest 138: 1125–1132.

4. LaurellCB, ErikssonS (1963) The electrophoretic alpha 1 globulin pattern of serum in alpha 1 antitrypsin deficiency. Scand J Clin Lab Invest 15: 132–140.

5. CarrellRW, JeppssonJO, LaurellCB, BrennanSO, OwenMC, et al. (1982) Structure and variation of human alpha 1-antitrypsin. Nature 298: 329–334.

6. LuisettiM, SeersholmN (2004) Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax 59: 164–169.

7. Global Initiative for Obstructive Lung Disease.Available: http://www.goldcopd.org. Accessed June 2013.

8. PillaiSG, GeD, ZhuG, KongX, ShiannaKV, et al. (2009) A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 5: e1000421.

9. HunninghakeGM, ChoMH, TesfaigziY, Soto-QuirosME, AvilaL, et al. (2009) MMP12, lung function, and COPD in high-risk populations. N Engl J Med 361: 2599–2608.

10. CalverleyPM, AndersonJA, CelliB, FergusonGT, JenkinsC, et al. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356: 775–789.

11. ChapmanKR, StockleyRA, DawkinsC, WilkesMM, NavickisRJ (2009) Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis. COPD 6: 177–184.

12. StockleyRA, ParrDG, PiitulainenE, StolkJ, StoelBC, et al. (2010) Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respir Res 11: 136.

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2013 Číslo 8
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#